JPS57146710A - Blood brain-barrier permeating ribosome-like microcapsule - Google Patents

Blood brain-barrier permeating ribosome-like microcapsule

Info

Publication number
JPS57146710A
JPS57146710A JP3273781A JP3273781A JPS57146710A JP S57146710 A JPS57146710 A JP S57146710A JP 3273781 A JP3273781 A JP 3273781A JP 3273781 A JP3273781 A JP 3273781A JP S57146710 A JPS57146710 A JP S57146710A
Authority
JP
Japan
Prior art keywords
enzymes
microcapsule
blood brain
ribosome
sulfatide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP3273781A
Other languages
English (en)
Other versions
JPS648601B2 (ja
Inventor
Kunio Yagi
Makoto Naoi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to JP3273781A priority Critical patent/JPS57146710A/ja
Publication of JPS57146710A publication Critical patent/JPS57146710A/ja
Publication of JPS648601B2 publication Critical patent/JPS648601B2/ja
Granted legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/127Liposomes
    • A61K9/1271Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Dispersion Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
JP3273781A 1981-03-07 1981-03-07 Blood brain-barrier permeating ribosome-like microcapsule Granted JPS57146710A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP3273781A JPS57146710A (en) 1981-03-07 1981-03-07 Blood brain-barrier permeating ribosome-like microcapsule

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP3273781A JPS57146710A (en) 1981-03-07 1981-03-07 Blood brain-barrier permeating ribosome-like microcapsule

Publications (2)

Publication Number Publication Date
JPS57146710A true JPS57146710A (en) 1982-09-10
JPS648601B2 JPS648601B2 (ja) 1989-02-14

Family

ID=12367140

Family Applications (1)

Application Number Title Priority Date Filing Date
JP3273781A Granted JPS57146710A (en) 1981-03-07 1981-03-07 Blood brain-barrier permeating ribosome-like microcapsule

Country Status (1)

Country Link
JP (1) JPS57146710A (ja)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS62129221A (ja) * 1985-11-29 1987-06-11 Oyo Seikagaku Kenkyusho:Kk アドリアマイシン包埋リポソ−ム製剤
JPS63275522A (ja) * 1987-05-01 1988-11-14 Terumo Corp 人工赤血球及びその製造方法
US4920016A (en) * 1986-12-24 1990-04-24 Linear Technology, Inc. Liposomes with enhanced circulation time
US5073543A (en) * 1988-07-21 1991-12-17 G. D. Searle & Co. Controlled release formulations of trophic factors in ganglioside-lipsome vehicle
WO2007009404A1 (es) 2005-07-22 2007-01-25 Centro de Investigación y Desarrollo de Medicamentos (CIDEM) Formulaciones nasales de eporh con bajo contenido de ácido siálico para el tratamiento de enfermedades del sistema nervioso central.

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0651802U (ja) * 1992-10-31 1994-07-15 京都度器株式会社 合成樹脂製計測テープ

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS53142514A (en) * 1977-05-10 1978-12-12 Ici Ltd Freeze dried latent liposome mixture * aqueous liposome preparation and production thereof
JPS5598121A (en) * 1978-10-02 1980-07-25 Procter & Gamble Lipid membrane drug transmission

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS53142514A (en) * 1977-05-10 1978-12-12 Ici Ltd Freeze dried latent liposome mixture * aqueous liposome preparation and production thereof
JPS5598121A (en) * 1978-10-02 1980-07-25 Procter & Gamble Lipid membrane drug transmission

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS62129221A (ja) * 1985-11-29 1987-06-11 Oyo Seikagaku Kenkyusho:Kk アドリアマイシン包埋リポソ−ム製剤
US4920016A (en) * 1986-12-24 1990-04-24 Linear Technology, Inc. Liposomes with enhanced circulation time
JPS63275522A (ja) * 1987-05-01 1988-11-14 Terumo Corp 人工赤血球及びその製造方法
US5073543A (en) * 1988-07-21 1991-12-17 G. D. Searle & Co. Controlled release formulations of trophic factors in ganglioside-lipsome vehicle
WO2007009404A1 (es) 2005-07-22 2007-01-25 Centro de Investigación y Desarrollo de Medicamentos (CIDEM) Formulaciones nasales de eporh con bajo contenido de ácido siálico para el tratamiento de enfermedades del sistema nervioso central.

Also Published As

Publication number Publication date
JPS648601B2 (ja) 1989-02-14

Similar Documents

Publication Publication Date Title
PT83872B (pt) Processo de preparacao de compostos de fosforo e de medicamentos contendo-os
ATA86885A (de) Verfahren zur herstellung lagerstabiler, schnellzerfallender pharmazeutischer wirkstoff-presslinge
ATE41307T1 (de) Waessrige, eine fettloesliche wirksubstanz enthaltende loesung sowie verfahren zu deren herstellung.
DE59004337D1 (de) Sterole, deren fettsäureester und glucoside; verfahren zu ihrer herstellung; spontan dispergierbare mittel mit diesen verbindungen, sowie ihre verwendung zur behandlung von tumoren.
NO161674C (no) Analogifremgangsm te for fremstilling av terapeutisk aktive 6-substituert-s-triazolo(3,4-a)-ftalazinderivater.
NO171443C (no) Fremgangsmaate for fremstilling av farmasoeytiske preparater inneholdende syntetiske lipider
IL81868A (en) Aqueous phospholipid solutions containing hydroxyalkylamines and their esters
DE3580531D1 (de) Verfahren zur herstellung lagerstabiler waessriger praeparate von anionischen farbstoffen.
NO872356D0 (no) Fremgangsmaate til fremstilling av monokaliumfosfat.
DE3266360D1 (en) Medicines containing as active ingredients compounds of the arylbenzenesulfonamide-type, and processes for their preparation
FI854926A (fi) Foerfarande foer framstaellning av farmakologiskt aktiva pyrrolobensimidazoler.
NO162906C (no) Analogifremgangsmaate ved fremstilling av delta22- ellerdelta23- 26,26,26,27,27,27- heksafluor-1alfa,25-dihydroksycholecalciferol.
JPS57146710A (en) Blood brain-barrier permeating ribosome-like microcapsule
DE3886213D1 (de) Verfahren zur Herstellung von Antioxidant-Zubereitungen.
NO164654C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive (2-okso-1,2,3,5-tetrahydroimidazo (2,1-b)kinazolinyl)-oksylakylamider.
YU43576B (en) PROCESS FOR PREPARATION OF 7-PIPERIDINO-1,2,3,5-TETRA-HYDRO-IMIDAZO(2,1-b) QUINAZOLINE-2-ONES
NO872809L (no) FremgangsmŸte ved fremstilling av 5-amino-alicylsyre.
FI951126A (fi) Menetelmä ja seos hiuskadon hoitamiseen
PT69999A (de) 1,2,3-triazolcarbonsaureamide verfahren zur herstellung dieser verbindungen sowie diese enthaltende biozide mittel
AU565799B2 (en) 4-oxothiazolidin-2-ylidene-acetamide derivatives
HUT47299A (en) Process for producing pharmaceutical influencing cerebral metabolism and neuronal transmission
PT76582B (de) 1,2,4-triazol-1-yl-propionitrile verfahren zur herstellung dieser verbindungen sowie diese enthaltende biozide mittel
ATE57912T1 (de) Verfahren zur herstellung von anilinofumarat und 2,3-chinolindicarbonsaeure.
DE68915750D1 (de) Kathecholverbindungen, verfahren zur herstellung und arzneimittelzubereitung, die diese enthält.
EP0158299A3 (de) Substituierte Phenylethylderivate, Verfahren zu ihrer Herstellung und pharmazeutische Mittel